Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what comparative assessment his Department has made of the cost of treatment for (a) comas and (b) other severe episodes of Type 1 diabetes and the cost of surgically implanted glucose monitoring devices.
There is no comparative assessment on the cost of treatment for either comas or other severe episodes of Type 1 diabetes, or on the cost of surgically implanted glucose monitoring devices.
Treatments may be brought into routine use in the National Health Service after their cost-effectiveness has been appropriately demonstrated. The National Institute for Health and Care Excellence is responsible for assessing new technologies and interventional procedures.